相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Serotonin and brain function: a tale of two receptors
R. L. Carhart-Harris et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future
Robin L. Carhart-Harris et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms
Robin L. Carhart-Harris et al.
SCIENTIFIC REPORTS (2017)
Patients' Accounts of Increased Connectedness and Acceptance After Psilocybin for Treatment-Resistant Depression
Rosalind Watts et al.
JOURNAL OF HUMANISTIC PSYCHOLOGY (2017)
Trajectories of relapse in randomised, placebo-controlled trials of treatment discontinuation in major depressive disorder: an individual patient-level data meta-analysis
Ralitza Gueorguieva et al.
LANCET PSYCHIATRY (2017)
Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression A SPECT Study
Rafael Faria Sanches et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2016)
Psychedelics in the treatment of unipolar mood disorders: a systematic review
James J. H. Rucker et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Roland R. Griffiths et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
Stephen Ross et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology
Ido Hartogsohn
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach
Gael Qesseveur et al.
NEUROPHARMACOLOGY (2016)
Question-based Drug Development for psilocybin Reply
Robin L. Carhart-Harris et al.
LANCET PSYCHIATRY (2016)
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
Robin L. Carhart-Harris et al.
LANCET PSYCHIATRY (2016)
Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population
Peter S. Hendricks et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
European rating of drug harms
Jan van Amsterdam et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
Michael P. Bogenschutz et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
LSD enhances the emotional response to music
M. Kaelen et al.
PSYCHOPHARMACOLOGY (2015)
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report
Flavia de L. Osorio et al.
REVISTA BRASILEIRA DE PSIQUIATRIA (2015)
Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
Peter Gasser et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2014)
Repeated lysergic acid diethylamide in an animal model of depression: Normalisation of learning behaviour and hippocampal serotonin 5-HT2 signalling
Tobias Buchborn et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction
Matthew W. Johnson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
Converging translational evidence for the involvement of the serotonin 2A receptor gene in major depressive disorder
Anne-Cecile Petit et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2014)
Characterization of Treatment Resistant Depression Episodes in a Cohort of Patients from a US Commercial Claims Database
Nicole Kubitz et al.
PLOS ONE (2013)
Experienced Drug Users Assess the Relative Harms and Benefits of Drugs: A Web-Based Survey
Robin Lester Carhart-Harris et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2013)
Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials
Teri S. Krebs et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Personality, Psychopathology, Life Attitudes and Neuropsychological Performance among Ritual Users of Ayahuasca: A Longitudinal Study
Jose Carlos Bouso et al.
PLOS ONE (2012)
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Charles S. Grob et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
The double edged sword of neural plasticity: Increasing serotonin levels leads to both greater vulnerability to depression and improved capacity to recover
Igor Branchi
PSYCHONEUROENDOCRINOLOGY (2011)
Psychometric Evaluation of the Altered States of Consciousness Rating Scale (OAV)
Erich Studerus et al.
PLOS ONE (2010)
Human hallucinogen research: guidelines for safety
M. W. Johnson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
R. R. Griffiths et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder
Francisco A. Moreno et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Implication of 5-HT2 receptor subtypes in the mechanism of action of antidepressants in the four plates test
BA Nic Dhonnchadha et al.
PSYCHOPHARMACOLOGY (2005)
分享论文
